Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Rheumatology
•
Vasculitis
What is your approach to immunosuppression in an adult patient with biopsy-proven IgA vasculitis who has new and severe acute renal failure requiring dialysis?
Related Questions
Should patients starting cyclophosphamide be screened routinely for latent tuberculosis (TB)?
How would you manage a patient with severe Hurley Stage 3 active, draining, HS who is also currently requiring Rituxan for management of vasculitis?
Would you consider tocilizumab for treatment of GCA in patients with underlying CLL (not requiring therapy)?
Do you avoid tocilizumab in patients with prior bariatric surgery given the risk of GI perforation?
Is a persistently elevated IgE level clinically relevant in a patient who has otherwise good control of EGPA and completely suppressed eosinophils on mepolizumab?
Do you utilize temporal artery ultrasound in your practice?
What is your experience of using rituximab for GPA with renal involvement following a recent myocardial infarction?
How do you approach management of a young adult after ascending thoracic aneurysm repair with biopsy showing granulomatous inflammation (no other vascular involvement, PET scan normal)?
How long do you continue PJP prophylaxis in a patient with GPA who is able to wean steroids and remains only on rituximab for maintenance therapy?
What features on CTA/MRA are most helpful for differentiating large vessel vasculitis from atherosclerosis?
